Chronic Shoulder Pain Treatment: High Intensity Laser or Ultrasound
NCT ID: NCT02793401
Last Updated: 2016-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
141 participants
INTERVENTIONAL
2015-05-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
NCT05564182
HILT and US Therapies in Adhesive Capsulitis
NCT05210036
Physical Therapy in Shoulder Impingement Syndrome
NCT04779190
HILT or Conventional Combined Physical Therapy, in the Management of Hemiplegic Shoulder Pain
NCT06407596
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
NCT04669405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Group 1: Hotpack (HP)+ Balneotherapy+ Exercise + HILT
* Group 2: Hotpack (HP)+ Balneotherapy+ Exercise + US
Patients in both groups received HP to the affected shoulder region for 20 minutes and balneotherapy, in mineral water pool at 38-400C for 20 minutes, for seven consecutive days. ROM exercises and Codman exercises, in a level not to increase the severity of the pain of the patient, were given and stretching and strengthening exercises were taught to the patients.The patients performed these exercises daily in two sets with five repeats in each set.
HILT was performed using a BTL-6000 High Intensity Laser, 12 W(watt), 1064 nm device was a hot laser with Nd: YAG LASER source. BTL 4710 US device was applied at 3 MHz frequency, and 1.5watt/cm2 intensity over 25 cm2 surface area. Headpiece area of the device was 5 cm2, and the application was performed as the head of device was positioned at 90º (perpendicular) at full contact for 5 minutes by using gel, and performing continuous circular motions. Patients were evaluated using VAS and SPADI in pre-treatment (Pre-T), Post-T1st day and Post-T 30th day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HILT group
71 of the patients were in the HILT group
Hıgh İntensity Laser (HILT)
HILT was performed using a BTL-6000 High Intensity Laser, 12 W(watt), 1064 nm device was a hot laser with Nd: YAG LASER source. In HILT group, the investigators applied the device on the shoulder area in two phases: phase I - analgesia, and phase II - biostimulation.
Hotpack
All patients had the same physical therapy (PT) protocol including hot pack (HP) for 20 min/session,
Transcutaneous electrical nerve stimulation
All patients had the same physical therapy (PT) protocol includingTENS (Fizyotens 4000, Fizyomed Medical Devices Ltd,Turkey) (50-100 Hz) for 20 min/session,
Therapeutic exercises
All patients had the same physical therapy (PT) protocol including therapeutic exercises for shoulder muscles
Balneotherapy
All patients had the same physical therapy (PT) protocol including balneotherapy in 38-40 °C thermomineralized water for 20 minutes.
US Group
70 of the patients were in the US group.
Ultrasound
BTL 4710 US device was applied at 3 MHz frequency, and 1.5watt/cm2 intensity over 25 cm2 surface area. Headpiece area of the device was 5 cm2, and the application was performed as the head of device was positioned at 90º (perpendicular) at full contact for 5 minutes by using gel, and performing continuous circular motions.
Hotpack
All patients had the same physical therapy (PT) protocol including hot pack (HP) for 20 min/session,
Transcutaneous electrical nerve stimulation
All patients had the same physical therapy (PT) protocol includingTENS (Fizyotens 4000, Fizyomed Medical Devices Ltd,Turkey) (50-100 Hz) for 20 min/session,
Therapeutic exercises
All patients had the same physical therapy (PT) protocol including therapeutic exercises for shoulder muscles
Balneotherapy
All patients had the same physical therapy (PT) protocol including balneotherapy in 38-40 °C thermomineralized water for 20 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hıgh İntensity Laser (HILT)
HILT was performed using a BTL-6000 High Intensity Laser, 12 W(watt), 1064 nm device was a hot laser with Nd: YAG LASER source. In HILT group, the investigators applied the device on the shoulder area in two phases: phase I - analgesia, and phase II - biostimulation.
Ultrasound
BTL 4710 US device was applied at 3 MHz frequency, and 1.5watt/cm2 intensity over 25 cm2 surface area. Headpiece area of the device was 5 cm2, and the application was performed as the head of device was positioned at 90º (perpendicular) at full contact for 5 minutes by using gel, and performing continuous circular motions.
Hotpack
All patients had the same physical therapy (PT) protocol including hot pack (HP) for 20 min/session,
Transcutaneous electrical nerve stimulation
All patients had the same physical therapy (PT) protocol includingTENS (Fizyotens 4000, Fizyomed Medical Devices Ltd,Turkey) (50-100 Hz) for 20 min/session,
Therapeutic exercises
All patients had the same physical therapy (PT) protocol including therapeutic exercises for shoulder muscles
Balneotherapy
All patients had the same physical therapy (PT) protocol including balneotherapy in 38-40 °C thermomineralized water for 20 minutes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Receiving physical therapy and injection treatment to the same shoulder region in the previous year,
* Malignancy,
* The presence of radicular pain and cervical myofascial pain syndrome,
* A history of acute trauma,
* A prior history of fracture in the shoulder to be treated,
* A prior history of surgical intervention and implantation of a metal implant to the affected shoulder,
* Inflammatory rheumatoid disease.
35 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Burcu Metin Ökmen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burcu Metin Ökmen, MD
Role: STUDY_DIRECTOR
Bursa Yuksek Ihtisas Education and Research Hospital
Korgün Ökmen, MD
Role: PRINCIPAL_INVESTIGATOR
Bursa Yuksek Ihtisas Education and Research Hospital
Kağan Özkuk, MD
Role: STUDY_CHAIR
Abant İzzet Baysal Physical Therapy and Rehabilitation Education and Research Hospital
Bilal Uysal, MD
Role: STUDY_CHAIR
Abant İzzet Baysal Physical Therapy and Rehabilitation Education and Research Hospital
Refia Sezer, MD
Role: STUDY_CHAIR
Abant İzzet Baysal Physical Therapy and Rehabilitation Education and Research Hospital
Engin Koyuncu, MD
Role: STUDY_CHAIR
Ankara Physical Therapy and Rehabilitation Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Bursa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BursaYIERH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.